The VEGFC gene helps your body build and maintain lymphatic vessels, which drain extra fluid from tissues and support immune function. If this gene does not work properly, fluid can collect in the arms, legs, or other areas, which can lead to inherited lymphedema. This gene also helps guide the growth of certain blood vessels during early development. Some people carrying a VEGFC variant may notice swelling that starts in childhood or later in life.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the working parts of cells. Others mainly guide when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. More detail on this topic is available in the LearnHub.
Overview
VEGFCGene function
What if the gene works
The VEGFC gene helps your body build and maintain lymphatic vessels, which move fluid and support immune function. It also supports some blood vessel growth and tissue development.
Risk
What if the gene does not work
Variants in the VEGFC gene are linked to inherited primary lymphedema, often with leg swelling from birth or early childhood. Effects can range from mild to more marked, depending on how strongly the variant disrupts lymph vessel growth and drainage.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the VEGFC gene, no VEGFC-specific treatment or medication choice is currently established in clinical guidelines. The VEGFC pathway is being studied as a possible drug target and biomarker in lymphatic conditions and some cancers, but this has not yet changed routine care.
Conditions associated with VEGFC
Gene function
What if the gene works
Your tissues constantly shift small amounts of fluid in and out of blood vessels. The VEGFC gene helps build and maintain lymph vessels, the tiny channels that collect extra fluid and return it to circulation. Its protein serves as a growth signal for vessel-lining cells. This explains what the VEGFC gene does in the lymphatic system and why it matters for everyday fluid balance.
The VEGFC gene makes a signal that tells certain vessel-lining cells to grow and form lymph vessels. During normal development, this helps create the bodywide network that drains fluid from tissues.
Its protein helps lymph vessel cells move, connect, and organize into branching pathways. This gives the lymphatic network a clear layout so fluid can travel in an orderly way.
By supporting healthy lymph vessels, the VEGFC gene helps tissues send extra fluid, proteins, and other material back toward the bloodstream. This supports normal day to day fluid balance.
Lymph vessels supported by the VEGFC gene also act as travel routes for immune cells. This helps immune cells reach lymph nodes, where the body monitors for germs and coordinates responses.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the VEGFC gene linked to lymphedema reduce how much VEGF-C protein is made, how well it is processed and released from cells, or how strongly it binds its receptor on lymph vessel cells. Milder changes may leave some signaling in place. More disruptive variants can reduce signaling much more. In affected families, this stronger loss of activity is often tied to earlier onset or more noticeable swelling, although effects vary between people.
How variants are linked to conditions
Pathogenic variants in the VEGFC gene are a recognized cause of some forms of hereditary primary lymphedema, often with swelling of the feet and legs from birth or early childhood. In some families, this may be described as Milroy-like lymphedema. Severity can vary, even among relatives carrying the same VEGFC gene variant.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a VEGFC gene change linked to lymphedema, the inherited variant is the main reason risk is higher. Swelling can be more likely to appear or get worse after infection, injury, surgery, weight gain, or long periods of standing. These steps can help limit flare-ups and complications, but there is not enough evidence to say they remove the inherited risk.
Inheritance of VEGFC variants
The inheritance of VEGFC gene variants linked to primary lymphedema is usually autosomal dominant. This means a person with a disease-causing variant in one copy of the VEGFC gene can pass it to a child, with a 1 in 2, or 50%, chance in each pregnancy. Sons and daughters can inherit it equally, and either parent can pass it on. Some people in the same family may be affected more noticeably than others, even when they carry the same VEGFC gene variant.
What does my VEGFC result mean for my family?
Some changes in the VEGFC gene are linked to an inherited form of lymphedema, a condition that can cause long-term swelling, often in the legs. In families with this kind of VEGFC result, close relatives such as parents, brothers, sisters, and children may also carry the same change, even if symptoms are milder or started later. This can help explain a family history of unexplained limb swelling and may be useful information for relatives discussing their own health care.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the VEGFC gene, a lab can analyze DNA from blood, saliva, or a cheek swab. This VEGFC genetic testing reads the gene’s sequence and checks for changes linked to lymphatic conditions. Results may show a known variant, no variant, or a change that doctors cannot yet fully interpret.
When should I consider getting a genetic test?
Genetic testing for the VEGFC gene may be worth considering if you or your child has ongoing swelling from fluid buildup, especially from birth or early childhood, or if several relatives have similar swelling. A VEGFC result can help show whether an inherited form of lymphedema is involved.
A genetic result is only one part of your health story
A genetic result can be very informative, but how much it reveals depends on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body responds to medicines. Small inherited differences can affect how a drug is broken down, how much of it reaches its target, or how strongly your body reacts to it. This helps explain why the same treatment works well for one person, seems weaker in another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medicines. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more personalized. If you want to learn more about this topic, you can explore it further in the LearnHub.
Drugs influenced by the VEGFC gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about treatment, side effects, or new symptoms are best discussed with your doctor.